Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response. - Cui X; Cao Z; Wang S; Lee RB; Wang X; Murata H; Adler SP; McVoy MA; Snapper CM (Vaccine, 2018)